SIR -I congratulate Ben A. Barres on his excellent Commentary "Does gender matter?" (Nature 442, 133-136; 2006) . I was struck by the paucity of female plenary lecturers at the Bioscience 2006 meeting of the UK Biochemical Society. Spurred on by Barres's comment that too few women academics speak out against prejudice, I decided to do a little research on the matter.
There have been three meetings of the Biochemical Society in the new annual meeting format (Biosciences 2004 (Biosciences , 2005 (Biosciences and 2006 and at these 1 of 10, 0 of 10 and 0 of 7, respectively, of the plenary lectures were given by a woman. Some of these plenary lecturers were recipients of prizes and medals, and I was so shocked by these statistics that I made a rough count of the proportion of women who have received these prizes over the years, as published on the society's website at www.biochemsoc.org.uk. Recipients' initials, rather than first names, are given, so I may conceivably have misattributed the male gender to some of the earlier names.
The prizes include the annual Colworth medal, given to a promising scientist Furthermore, the statistics have not improved. In the past ten years, none of the Colworth medals has been awarded to women -and it is prizes such as these, given to scientists early in their career, that influence their future success. The results speak for themselves: that people will always give prizes to others in their own image, unless forced to take sexual and racial bias into account. I wonder if the record of other scientific societies is much better in this regard.
I should also point out that UK Biochemical Society meetings are supported by funds from the Biotechnology and Biological Sciences Research Council and by the European Molecular Biology Organization. Why do research funding bodies not assert leverage on this matter, by insisting that sexual and racial bias in speaker selection must be addressed at any meeting for which their financial support is given? We identified several differences, including changes made by the NIH, that would predict a decrease in the activation of automatic gender stereotypes that may have discouraged women from applying and disadvantaged women applicants in the first round.
First, a reduction in the number of applicants (from 1,300 to 840) and greater familiarity with an application process that was no longer new may have reduced time pressure on the reviewers.
Second, the NIH removed the repeated mention of the need for applicants to engage in 'high-risk' research; we believe that this terminology encouraged male and discouraged female applicants. Similarly, the emphasis on 'intrinsic' leadership abilities and 'potential' of the scientist was removed, in favour of an emphasis on the scientist's research.
Third, there was a much higher proportion of women in the applicant pool, which may have been related to the change in language Fourth, the presence of accomplished women scientists on the review committee provided a positive role model for applicants.
Finally, women were specifically encouraged to apply -a particularly significant factor in the context of the outcry in the scientific community following the absence of women in the first round.
We applaud the NIH for taking an evidence-based approach. Regardless of the gender composition of the group selected in the forthcoming third round, removal of conditions that are known to activate automatic gender stereotypes ensures that the best science will be supported, regardless of the sex of the scientist.
A positive definition of prokaryotes
SIR -In his Concepts essay, Norman R. Pace argues that the concept of prokaryotes is misleading and proposes that the word 'prokaryote' be banned from the scientific literature 1 . We disagree. Pace contends that the term prokaryote refers to the lack of a nucleus and that it is hence a "negative and therefore scientifically invalid description" of cell organization, because "no one can define what is a prokaryote". The former is a matter of opinion, and the latter is arguably incorrect.
Prokaryotes are cells with co-transcriptional translation on their main chromosomes; they translate nascent messenger RNAs into protein. 
